Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
Naslov
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
Identifikator
/unibl/sci/idNaucniRad:23027
Tip
Pronađite slične unoseAcademic Article
Datum
Pronađite slične unose2016-06
Bibliografski citat
J. Escaned, A. Banning, V. Farooq, M. Echavarria-Pinto, Y. Onuma, N. Ryan, R. Calvacante, C. Campos, B. Stanetić, Y. Ishibashi, P. Suwannasom, A. Kappetein, D. Taggart, M. Morel, G. van Es, P. Serruys, Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease., EuroIntervention, Vol. 12, No. 2, pp. 224 - 234, Jun, 2016
Početna stranica
224
Krajnja stranica
234
Je dio
EuroIntervention
1969-6213
Lista autora
Position: 498 (61 views)